Columbia Wanger Asset Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | $30.6M | Buy |
|
|||||
2017
Q3 | $14.9M | Sell |
|
|||||
2017
Q2 | $21.1M | Buy |
|
|||||
2017
Q1 | $21.7M | Sell |
|
|||||
2016
Q4 | $21.9M | Buy |
|
|||||
2016
Q3 | $11.7M | Sell |
|
|||||
2016
Q2 | $23.1M | Buy |
|
|||||
2016
Q1 | $11.3M | Sell |
|
|||||
2015
Q4 | $56.6M | Buy |
|
|||||
2015
Q3 | $32.8M | Buy |
|
|||||
2015
Q2 | $65.4M | Sell |
|
|||||
2015
Q1 | $78.1M | Sell |
|
|||||
2014
Q4 | $58.3M | Sell |
|
|||||
2014
Q3 | $46.3M | Sell |
|
|||||
2014
Q2 | $58.5M | Buy |
|
|||||
2014
Q1 | $47.2M | Buy |
|
|||||
2013
Q4 | $40.5M | Buy |
|